This blog breaks down prices, showing what you should expect to pay for well-known drugs like Ozempic, Wegovy, and Rybelsus, which are glucagon-like peptide-1 (GLP-1) receptor agonists
The idea is that tiny doses can give benefits with fewer side effects
A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial weight loss in adults with Type 1 diabetes who use automated insulin delivery systems
However, setmelanotide (Imcivree), an MC4 receptor agonist, received FDA approval in 2020 for weight management related to certain genetic defects that can lead to severe obesity at a young age
However, the effectiveness and suitability of these alternatives vary from person to person, and a healthcare provider should be consulted for personalized treatment advice